FULC

FULCRUM THERAPEUTICS, INC.

FULC · CIK 1680581 · Annual (10-K) · Last 7 years

Financial Trends

Revenue
20192025
Net Income−$75M
20192025
Operating CF−$60M
20192025
Free Cash Flow−$60M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue———————
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense———————
Operating Income$-0.1B$-0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
Net Income$-0.1B$-0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-1.18$-0.16$-1.59$-2.44———
EPS (Diluted)$-1.18$-0.16$-1.59$-2.44———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.4B$0.3B$0.3B$0.2B$0.2B$0.1B$0.1B
Current Assets$0.4B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B
Cash & Equivalents$0.2B$0.1B$0.0B$0.0B$0.0B$0.1B$0.1B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.3B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.1B$-0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.0B$0.0B$-0.0B$0.0B$-0.1B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.2B$0.0B$0.1B$0.1B$0.2B$0.1B$0.1B
← Companies